SWI/SNF (BAF) Complex Mutations in Cancer

preview_player
Показать описание
Charles Robert, MD, PhD
St. Judes Research Hospital
  1. CU Cancer Center
Рекомендации по теме
SWI/SNF (BAF) Complex 1:03:30

SWI/SNF (BAF) Complex Mutations in Cancer

SWI/SNF Nucleosome remodeling 0:07:03

SWI/SNF Nucleosome remodeling complex

Structure and Function 0:43:21

Structure and Function of Mammalian SWI/SNF (BAF) Complexes in Synovial Sarcoma

SWI/SNF (Will Smith) 0:00:17

SWI/SNF (Will Smith) complex unwinds DNA from nucleosome

Taking a second 1:06:02

Taking a second look at the MYC-SWI/SNF interaction

SWI/SNF Mutations in 0:20:33

SWI/SNF Mutations in Cancer - Diana Hargreaves, Salk Institute

Structure and Function 0:47:23

Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Cancer

Diana Hargreaves - 0:39:27

Diana Hargreaves - Remodeling Chromatin: SWI/SNF Complex in Development, Disease: Chromatin-Con 2021

Structure and Function 1:01:51

Structure and Function of Epigentic Regulators in Human Disease

BAF Complex Combinatorial 0:00:30

BAF Complex Combinatorial Assembly

Targeting SWI/SNF-Hippo Axis 0:01:38

Targeting SWI/SNF-Hippo Axis in Squamous Cancers

Targeting Cancer Pathways: 0:56:36

Targeting Cancer Pathways: The Epigenetics Question

System for Studying 0:17:10

System for Studying the BAF Chromatin and Remodeling Complex in Cancer

Genome-wide Mapping of 1:00:57

Genome-wide Mapping of Protein-DNA Interaction Dynamics

smarce1 mutants have 0:00:59

smarce1 mutants have a defective endocardium and an increased expression of cardiac transcription

Chromatin Remodeling in 0:04:01

Chromatin Remodeling in Eukaryotes

LMP Grand Rounds 1:00:23

LMP Grand Rounds BWeissman 8Nov2017

Day 6 Podcast 0:30:50

Day 6 Podcast Epigenetics Chromatin Remodeling and Intro to Methlation

Marco Trizzino: 'Inability 0:37:19

Marco Trizzino: 'Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from ...'

Chromatin Remodeler Brahma 0:20:36

Chromatin Remodeler Brahma Safeguards Canalization in Cardiac Mesoderm Differentiation

Tumors characterized by 0:00:31

Tumors characterized by the loss of SMARCB1/ INI1

Specific, High affinity 0:03:52

Specific, High affinity Antibodies for Discovery | Customer Spotlight with Cigall Kadoch, PhD

GuotaiXu, MSKCC: ARID1A 0:24:33

GuotaiXu, MSKCC: ARID1A determines luminal identity & therapeutic response in ER+ breast cancer

Structure Based SMARCA2 0:01:28

Structure Based SMARCA2 PROTAC Design

Комментарии
Автор

Can someone point me towards any resources since this talk in 2017 regarding the understanding of or any potential therapeutic approaches developed towards SMARCB1 loss? Thank you very much.

jeandivine